Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer. - Wikidata - wikimedia - TriplyDB

Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer.

Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer.

http://www.wikidata.org/entity/Q37241740

about

Anti-inflammatory/antioxidant use in long-term maintenance cancer therapy: a new therapeutic approach to disease progression and recurrence Zebrafish small molecule screens: Taking the phenotypic plunge Optical metabolic imaging of treatment response in human head and neck squamous cell carcinoma Photothermal optical lock-in optical coherence tomography for in vivo imaging Magnetization Transfer MRI Contrast May Correlate with Tissue Redox State in Prostate Cancer Metabolic fingerprinting of bacteria by fluorescence lifetime imaging microscopy.Multicolor two-photon imaging of endogenous fluorophores in living tissues by wavelength mixing.The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis.In vivo hyperspectral imaging of microvessel response to trastuzumab treatment in breast cancer xenografts.Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer.Breast cancer redox heterogeneity detectable with chemical exchange saturation transfer (CEST) MRI.In vivo nonlinear spectral imaging as a tool to monitor early spectroscopic and metabolic changes in a murine cutaneous squamous cell carcinoma model.High-throughput measurements of the optical redox ratio using a commercial microplate reader.Collagen density and alignment in responsive and resistant trastuzumab-treated breast cancer xenografts Tumor mechanics and metabolic dysfunction.Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.Deconvolution of fluorescence lifetime imaging microscopy by a library of exponentials.Correlating two-photon excited fluorescence imaging of breast cancer cellular redox state with seahorse flux analysis of normalized cellular oxygen consumption.Temporal binning of time-correlated single photon counting data improves exponential decay fits and imaging speed.Metabolic Imaging of Head and Neck Cancer Organoids A quantitative framework for the analysis of multimodal optical microscopy images Drug response in organoids generated from frozen primary tumor tissues.Label-free imaging of metabolism and oxidative stress in human induced pluripotent stem cell-derived cardiomyocytes Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response.In Vivo Visualization of Stromal Macrophages via label-free FLIM-based metabolite imaging.Radiation Promptly Alters Cancer Live Cell Metabolic Fluxes: An In Vitro Demonstration.ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer Depth-resolved analytical model and correction algorithm for photothermal optical coherence tomography Imaging Sensitivity of Quiescent Cancer Cells to Metabolic Perturbations in Bone Marrow Spheroids Two-photon excited fluorescence of intrinsic fluorophores enables label-free assessment of adipose tissue function mTOR complex-2 stimulates acetyl-CoA and de novo lipogenesis through ATP citrate lyase in HER2/PIK3CA-hyperactive breast cancer Spatial dynamics of SIRT1 and the subnuclear distribution of NADH species.Optical redox ratio identifies metastatic potential-dependent changes in breast cancer cell metabolism.In Vivo Autofluorescence Imaging of Tumor Heterogeneity in Response to Treatment.Blind deconvolution estimation of fluorescence measurements through quadratic programming.Quadratic blind linear unmixing: A graphical user interface for tissue characterization.Autofluorescence imaging captures heterogeneous drug response differences between 2D and 3D breast cancer cultures.Transient absorption imaging of hemes with 2-color, independently tunable visible-wavelength ultrafast source.Optical metabolic imaging quantifies heterogeneous cell populations.Autofluorescence flow sorting of breast cancer cell metabolism.

P2860

Q27010314-91A524E2-F1B3-40F8-A352-610C740C8A74 Q28073655-96280A72-576A-4BD4-A520-589CDD2F264D Q28540413-3218ED8B-5D70-45DE-9472-35D99961045E Q30408505-E3EDEE48-3C5A-49C8-9FF8-1EE417E79838 Q33621051-E062AF29-4A5D-48AF-A45D-C4DD52302065 Q33807803-5FC332E2-9FEF-4A91-8107-5941A3094EEC Q33812892-9938A82A-A5F3-41F9-B652-F6DEC8FC7F43 Q33823191-D428B5C4-103E-4E94-8583-92F1B34A2675 Q33915825-7180C6EA-97FC-4E0B-95B7-BBF0F95E9921 Q34205196-A7B0EE52-63FD-4806-BA56-1844F099CE32 Q34611146-E78FB322-AC20-4067-BAAE-7A939C24D229 Q34848837-6549B95D-6B9B-4C2F-9613-BF52141BFCA4 Q35029198-F1A93DE2-2673-4780-B3D1-2DD5E2748E2C Q35105141-7CFD847D-04B6-46A3-9BFC-5575B43F567B Q35117423-B073AE77-457D-4254-84ED-2CA5A5649694 Q35740663-66CF9B56-63C8-4E5E-AA8F-CF833C5AD985 Q35774073-5177AA38-05F8-4104-BC34-77D99B7817A4 Q36051797-33E09D41-B5F2-45EA-B812-56CA2F42FEB8 Q36083518-A17B736E-EA48-466A-B6E4-952DDD6B9766 Q36252747-B20D1D0B-88B6-4AD5-83D2-538C97E8105A Q36301593-44AAF6F2-12A6-4783-A8F0-F0734EBFCDA4 Q36438337-8FC07290-A088-4D9B-AB77-FC1C7F727A0E Q36912011-8F22AF7B-7B8D-4669-89C7-8A67209DEC07 Q36922301-67338FB2-0D46-4B64-B007-EA539B501B54 Q36934018-AA1A2C7B-0C4C-4B52-86AD-2BD5088CFF9D Q36941952-BEE6D8A5-8ABB-4975-8C6E-720E7FB65C4F Q37096669-E99F137B-12A0-47DF-A7AE-779C89DE12A2 Q37103173-F72FA5BE-2F13-41CA-BC2F-57F369C50F8C Q37130950-DBD3B1A6-DE8F-4A97-A01A-8C4C151F3B1E Q37153734-0DA2FE0D-DE27-4F57-B148-946EFB6EE284 Q37295289-86CB5904-8243-460C-BB15-F91DB6C9A997 Q37417990-DB60C626-F179-40D6-AB74-3D40E00EA00C Q37429091-FC5B89D7-AF5D-460F-9D07-C4A4347C324A Q38809622-54649B2F-DBB7-48F7-901B-296D17D3B7D3 Q38848135-F23FBF31-D398-429D-9F6A-69902D40A933 Q39793364-07CC7AD8-7F7D-465A-87CB-FCFD570317A5 Q41068676-42C318D9-A76F-47C5-BBEA-A1A9E4AAFC7D Q41069821-FCB60EE9-F947-41FD-9994-92086F8256AF Q41205147-D7F30C2F-B6C4-4F85-AA5D-14ADCF83A140 Q41285978-6024CA2B-22B9-48C8-806B-1889195D4F89

P2860

Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer.

http://www.wikidata.org/entity/Q37241740

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Optical metabolic imaging iden ...... ent response in breast cancer.

@en

Optical metabolic imaging iden ...... ent response in breast cancer.

@nl

type

label

Optical metabolic imaging iden ...... ent response in breast cancer.

@en

Optical metabolic imaging iden ...... ent response in breast cancer.

@nl

prefLabel

Optical metabolic imaging iden ...... ent response in breast cancer.

@en

Optical metabolic imaging iden ...... ent response in breast cancer.

@nl

P1433

Q37241740-7C299E07-12CA-4DFD-9531-8C37535B38F8

P1476

Q37241740-5514C922-409F-4B45-A451-0F5BE2BA0515

P2093

Q37241740-29D8064A-DED9-4349-9346-238246F60A50

Q37241740-9312C187-3F4A-47F0-AD15-0937568CD91A

Q37241740-9AF5DAF7-A5D8-4E1C-929C-FE17DEF387D5

Q37241740-9B1E8BD1-31CD-494F-B795-3CDADE05A655

Q37241740-CB77CE23-293A-4A99-8D6F-E0FB915CFD1A

Q37241740-CBCD736E-64D7-4275-93A5-B549909046D7

Q37241740-E4ADCD8E-5BEA-44CE-8495-43698F019155

P2860

Q37241740-01497BB2-EB4D-4DAA-A866-C15CAD646AE9

Q37241740-09FADDFF-E240-4BFC-BF80-179882B15A33

Q37241740-110C8FAD-4684-407A-8B6C-5B167ACF29EC

Q37241740-12EC8E3B-D791-4ACA-84CE-526BCC85ABFD

Q37241740-16D7D775-E8E9-4557-A982-B2C44D43EB77

Q37241740-200FAA74-A4F4-41F8-BF3A-D87ABA3079B7

Q37241740-231E5980-3516-4F82-8B3D-8422B9EA0C4D

Q37241740-265379A9-DCD9-421B-AB00-AB86C3A0017D

Q37241740-2B2A08AB-0497-4B95-8747-E124644B4196

Q37241740-3004FBC0-8015-43D8-AC59-9C4C7FD14BA1

P304

Q37241740-D85C2B3D-3F71-470F-BB8C-F2471440DCAF

P31

Q37241740-25F52DD5-7F5D-4906-B4C9-C4A9D057B610

P356

Q37241740-5E1A3C7C-B882-4F2B-B596-DC40601E0D15

P407

Q37241740-BDACBAB3-99E3-403D-B8F6-ED2CAF85A84E

P433

Q37241740-C091059F-9DA3-4BAD-BA5C-7F56CD9E39AA

P478

Q37241740-FF841612-FC82-4C85-B7B2-AEF694CD2100

P577

Q37241740-78B6D901-45D6-48DE-8B4F-73D7147648E0

P698

Q37241740-D55861DD-B0C7-4D3C-993A-B0A14E9FCFCF

P932

Q37241740-D365904F-1764-42B4-9A58-5FEC747C5F82

P356

0008-5472.CAN-13-0527

P1433

Cancer Research

P1476

Optical metabolic imaging iden ...... ent response in breast cancer.

@en

P2093

Alec Lafontant

http://www.w3.org/2001/XMLSchema#string

Alex J Walsh

http://www.w3.org/2001/XMLSchema#string

Carlos L Arteaga

http://www.w3.org/2001/XMLSchema#string

Donna J Hicks

http://www.w3.org/2001/XMLSchema#string

H Charles Manning

http://www.w3.org/2001/XMLSchema#string

Melissa C Skala

http://www.w3.org/2001/XMLSchema#string

Rebecca S Cook

http://www.w3.org/2001/XMLSchema#string

P2860

Fluorescence lifetime imaging of free and protein-bound NADH

On the Origin of Cancer Cells

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

Two-photon fluorescence spectroscopy and microscopy of NAD(P)H and flavoprotein.

Proteome analysis for the identification of in vivo estrogen-regulated proteins in bone.

Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer.

P304

6164-6174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-13-0527

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24130112

http://www.w3.org/2001/XMLSchema#string

P932

3801432

http://www.w3.org/2001/XMLSchema#string